Xeris Biopharma Holdings last closed at $10.13 (+11.56%) on 2026-10-05. Signals today: MA aligned. Listed on Nasdaq. Trailing 12 months PER is -102.0×. Its overall grade ranks 67 of 741 stocks in Healthcare.
About this company
Xeris Biopharma Holdings last closed at $10.13 (+11.56%) on 2026-10-05. Signals today: MA aligned. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A+ · 67/741
Valuation grade C+
Related stocks
- AmgenCompetitor
희귀질환·내분비/신경계 바이오 의약품 시장에서 경쟁
- Amphastar PharmaceuticalsCompetitor
주사제·응급의료용 의약품 분야에서 경쟁
- Eli LillyCompetitor
인슐린·대사질환 치료제 시장에서 경쟁
About Xeris Biopharma Holdings
- What technical signals does Xeris Biopharma Holdings (XERS) have?
- Xeris Biopharma Holdings current technical signals: MA alignment (score 0.81).
- Is Xeris Biopharma Holdings a cup-and-handle pattern?
- No. Xeris Biopharma Holdings has no valid Cup signal right now.
- What published figures are available for Xeris Biopharma Holdings?
- Market cap: $1.68B. Trailing 12 months PER: -102.0×. Latest quarter PBR: -179.85×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Xeris Biopharma Holdings, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy